Chapter 16

References

 

1. Lipinski B, Egyud LG.  Resistance of cancer cells to immune recognition and killing.  Med Hypotheses 2000; 54(3):456-60.

 

2. Han RF, Pan JG. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Urology. 2006 Jun;67(6):1216-23.

 

Totterman TH, Loskog A, Essand M. The immunotherapy of prostate and bladder cancer. BJU Int. 2005 Oct;96(5):728-35.

 

3. Pruthi RS, Derksen E, Gaston K.  Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors :  a review.  J Urol 2003; 169(6):2352-9.

 

Smyth GP, Stapleton PP, Barden CB, Mestre JR, Freeman TA, Duff MD, Maddali S, Yan Z, Daly JM.  Renal cell carcinoma induces prostaglandin E2 and T-helper type 2 cytokine production in peripheral blood mononuclear cells.  Ann Surg Oncol 2003; 10(4):455-62.

 

Cardi ,  Ciardelli TL, Ernstoff MS.  Therapeutic applications of cytokines for immunostimulation and immunosuppression: an update. Progress in Drug Research.  1996; 47:211-50

 

Stanojevic-Bakic N, Vuckovic-Dekic L, Radomirovic S, Juranic Z, Jovanovic N.  The influence of surgery and anesthesia on lymphocyte functions in breast cancer patients: in vitro effects of indomethacin.  Neoplasma. 46(1):54-60, 1999

 

De Visser KE, Kast WM.  Effects of TGF-beta on the immune system: implications for cancer immunotherapy. Leukemia. 13(8):1188-99, 1999.

 

4. Whiteside TL, Vujanovic NL, Herberman RB.  Natural killer cells and tumor therapy. Current Topics in Microbiology & Immunology.  230:221-44, 1998.

 

Brittenden J,  Heys SD, Ross J, Eremin O.  Natural killer cells and cancer.  Cancer.  77(7):1226-43, 1996

 

Vujanovic NL, Basse P, Herberman RB, Whiteside TL.  Antitumor functions of natural killer cells and control of metastases.  Methods (Duluth). 9(2):394-408, 1996

 

Fujisawa T, Yamaguchi Y.  Autologous tumor killing activity as a prognostic factor in primary resected non-small cell carcinoma of the lung. Cancer 1997; 79: 474-481

 

Kleist SV. Prognostic factors in breast cancer: theoretical and clinical apsects.  Anticancer Research 1996; 16: 3907-3912

 

Carballido J, Alvarez-Mon M, Solovera OJ, Menéndez-Ondina L, Durántez A. Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder.  J  Urol 1990; 143: 29-33

 

Berghella AM, Pellegrini P, Del Beato T, Maccarone D, Adorno D, Casciani CU. Prognostic significance of immunological evaluation in colorectal cancer.  Cancer Biotherapy & Radiopharmaceuticals 1996; 11(6):355-361.

 

5. Oates KK,  Schulof RS, Goldstein AL, Sztein MB.  Cancer-associated immune suppression: therapeutic alterations with chemical and biological agents.  In;  Principles of Cancer Biotherapy.  2nd Edition.  Robert K. Oldham, ed.  New York: Marcel Dekker, Inc.  1991; 141

 

6. Dirkyx, AEM, oude Egbrink MGA, Wagstaff J, Griffioen AW.  Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J Leukocyte Biol. 2006; Dec.  Epub Sept.. 22, 2006.

 

Adams, D.O.  Molecular biology of macrophage activation: a pathway whereby psychosocial factors can potentially affect health.  Psychosomatic Medicine  1994; 56: 316-327

 

Erickson KL, Hubbard NE.  A possible mechanism by which dietary fat can alter tumorigenesis: lipid modulation of macrophages function. Advances in Experimental Medicine & Biology.  1994; 364:67-81.

 

 

7. Grekou AN, Toliou T,  Stravoravdi P,  Patakiouta F, Tsoukalas T, Pinakidis M,  Keramidas G. Correlation of apoptosis with the distribution and composition of lymphocytic infiltrate in human breast carcinomas.  Anticancer Research.  1996; 16(6C):3991-5.

 

Greil R, Egle A, Villunger A.  On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model. Leukemia & Lymphoma. 31(5-6):477-90, 1998.

 

8. Berghella AM, Pellegrini P, Del Beato T, Marini M, Tomei E, Adorno D Casciani CU.  The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back.  Cancer Immunology, Immunotherapy. 45(5):241-9, 1998

 

Shurin MR, Lu L, Kalinski P, Stewart-Akers AM, Lotze MT.  Th1/Th2 balance in cancer, transplantation and pregnancy.  Springer Seminars in Immunopathology. 21(3):339-59, 1999

 

Pellegrini ,  Berghella AM, Del Beato T,  Cicia S, Adorno D, Casciani CU. Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunology, Immunotherapy.  42(1):1-8, 1996

 

Sato M, Goto S, Kaneko R, Ito M, Sato S, Takeuchi S.  Impaired production of Th1 cytokines and increased frequency of Th2 subsets in PBMC from advanced cancer patients.  Anticancer Research. 18(5D):3951-5, 1998.

 

Campbell MJ, Scott J, Maecker HT, Park JW, Esserman LJ. Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Res Treat. 2005 May;91(2):163-71.

 

9. Lappin MB, Campbell JD.  The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancy.  Blood Reviews. 14(4):228-39, 2000

 

Kidd P.  Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003; 8(3):223-46

 

10. Shurin MR, Lu L, Kalinski P, Stewart-Akers AM, Lotze MT.  Th1/Th2 balance in cancer, transplantation and pregnancy.  Springer Seminars in Immunopathology. 1999; 21(3):339-59

 

11. Esposito S.  Immune system and surgical site infections.  J Chemother 2001; 13 Spec No 1(1):12-6.

 

12. Orsi AJ, Tax AW, Nuamah I, Barsevick A, McCorkle R.  Natural killer cells over time in patients with colorectal cancer.  Cancer Practice,  1996; 4(5): 252-7

 

Beitsch P, Lotzova E, Hortobagyi G, Pollock R.   Natural immunity in breast cancer patients during neoadjuvant chemotherapy and after surgery.  Surgical Oncology.  1994; 3(4):211-9

 

Yeager MP, Colacchio TA, Yu CT, Hildebrandt L, Howell AL, Weiss J, Guyre PM. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers.  Anesthesiology. 83(3):500-8, 1995 Sep

 

Kotani N. Anesthesia, surgery, and the immune system. Curr Opin Anesthesiol. 1993;6:562-568.

 

13. Klatte T, Ittenson A, Röhl FW, Ecke M, Allhoff EP, Böhm M. Pretreatment with interferon-alpha2a modulates perioperative immunodysfunction in patients with renal cell carcinoma. Onkologie. 2008 Feb;31(1-2):28-34.

 

Oosterling SJ, van der Bij GJ, Mels AK, Beelen RH, Meijer S, van Egmond M, van Leeuwen PA. Perioperative IFN-alpha to avoid surgically induced immune suppression in colorectal cancer patients. Histol Histopathol. 2006 Jul;21(7):753-60.

 

14. Kennedy DD, Tucker KL, Ladas ED, Rheingold SR, Blumberg J, Kelly KM.  Low antioxidant vitamin intakes are associated with increases in adverse effects of chemotherapy in children with acute lymphoblastic leukemia. Am J Clin Nutr. 2004 Jun;79(6):1029-36.

 

Taj MM, Pearson AD, Mumford DB, Price L.  Effect of nutritional status on the incidence of infection in childhood cancer.  Pediatr Hematol Oncol 1993; 10(3):283-7.

 

15. Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002 Jul-Aug;64(4):604-11.

 

16. Raison CL, Demetrashvili M, Capuron L, Miller AH. Neuropsychiatric adverse effects of interferon-alpha: recognition and management.  CNS Drugs. 2005;19(2):105-23.

 

17. Woelkart K, Linde K, Bauer R. Echinacea for preventing and treating the common cold. Planta Med. 2008 May;74(6):633-7.

 

Shah SA, Sander S, White CM, Rinaldi M, Coleman CI. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis. 2007 Jul;7(7):473-80.

 

Schoop R, Klein P, Suter A, Johnston SL. Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin Ther. 2006 Feb;28(2):174-83.

 

Linde K, Barrett B, Wölkart K, Bauer R, Melchart D. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD000530.

 

Currier NL, Miller SC.  Natural killer cells from aging mice treated with extracts from Echinacea purpurea are quantitatively and functionally rejuvenated. Experimental Gerontology. 2000; 35(5):627-39

 

18. Coon JT, Ernst E.  Andrographis paniculata in the treatment of upper respiratory tract infections:  a systematic review of safety and efficacy.  Planta Med 2004; 70(4):293-8.

 

Rajagopal S, Kumar RA, Deevi DS, Satyanarayana C, Rajagopalan R.  Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata.  J Exp Ther Oncol 2003; 3(3):147-58.

 

19. Matthys H, Eisebitt R, Seith B, Heger M.  Efficacy and safety of an extract of Pelargonium sidoides (EPs7630) in adults with acute bronchitis.  A randomized, double-blind, placebo-controlled trial.  Phytomedicine 2003; 10 Suppl 4:7-17.

 

Bereznoy VV, Riley DS, Wassmer G, Heger M.  Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial.  Altern Ther Health Med 2003; 9(5):68-79.

 

20. Wallaert B, Aerts C, Colombel JF, Voisin C. Human alveolar macrophage antibacterial activity in the alcoholic lung.  Am Rev Resp Dis 1991;  144: 278-283.

 

D'Souza NB, Bautista AP, Bagby GJ, Lang CH, Spitzer JJ. Acute ethanol intoxication suppresses E.coli lipolysaccharide-enhanced glucose utilization by hepatic nonparenchymal cells.  Alcoholism  1991; 15: 249-254

 

21. Barve SS, Kelkar SV, Gobejishvilli L, Joshi-Barve S, McClain CJ.  Mechanisms of alcohol-mediated CD4+ T lymphocyte death: relevance to HIV and HCV pathogenesis. Frontiers in Bioscience. 7:1689-96, 2002

 

Ben-Eliyahu S,  Page GG,  Yirmiya R,  Taylor AN. Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nature Medicine.  2(4):457-60, 1996

 

Wu WJ, Pruett SB.  Ethanol decreases host resistance to pulmonary metastases in a mouse model: role of natural killer cells and the ethanol-induced stress response. International Journal of Cancer. 82(6):886-92, 1999

 

Mufti SI, Darban HR, Watson RR.  Alcohol, cancer, and immunomodulation.  Critical Reviews in Oncology-Hematology. 9(3):243-61, 1989.

 

Szabo G.  Consequences of alcohol consumption on host defence.  Alcohol & Alcoholism. 34(6):830-41, 1999

 

22. Steel JL, Geller DA, Gamblin TC, Olek MC, Carr BI. Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol. 2007 Jun 10;25(17):2397-405.

 

Levy S, Herberman R, Lippman M, d'Angelo T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer.  J Clin Oncol  1987; 5(3): 348-353

 

Levy SM, Herberman RB, Whiteside T, Sanzo K, Lee J, Kirkwood J. Perceived social support and tumor estrogen/ progesterone receptor status as predictors of natural killer cell acivity in breast cancer patients.  Psychosomatic Medicine  1990; 52: 73-77

 

Irwin, M.  Daniels, M.  Bloom, E.T., et al.  Life events, depressive symptoms and immune function.  Am J Psychiatry  1987; 144: 437

 

Arnetz BB, Wasserman J, Petrini B et al.  Immune function in unemployed women.  Psychosomatic Medicine  1987; 49:3

 

Fawzy FI, Kemeny ME, Fawzy NW, Elashoff R, Morton D, Cousins N, Fahey JL. A structured psychiatric intervention for cancer patients.  II.  Changes over time in immunological measures.  Arch. Gen. Psychiatr.  1990; 47: 729-735

 

Hall M. Baum A. Buysse DJ. Prigerson HG. Kupfer DJ. Reynolds CF 3rd. Sleep as a mediator of the stress-immune relationship.  Psychosomatic Medicine. 60(1):48-51, 1998

 

Schleifer SJ, Keller SE, Camerino M, Thornton JC, Stein M. Suppression of lymphocyte stimulation following bereavement.  JAMA  1983; 250: 374.  See also:  Bartrop, R. W. et al.  Depressed lymphocyte function after bereavement.  Lancet 1977; 1: 884

 

Calabrese JR, Kling MA, Gold PW. Alterations in immunocompetence during stress, bereavement and depression: focus on neuroendocrine regulation.  Am. J. Psychiatry 1987; 144: 1123

 

Kiecolt-Glaser JK, Fisher LD, Ogrocki P, Stout JC, Speicher CE, Glaser R. Marital quality, marital disruption, and immune function.  Psychosomatic Medicine 1987; 49: 13

 

Goodwin, J.S. et al.  The effect of marital status on stage, treatment and survival of cancer patients.  JAMA  1987; 258 (21): 3125-3130.

 

[1] 23. Bennett MP, Zeller JM, Rosenberg L, McCann J. The effect of mirthful laughter on stress and natural killer cell activity. Altern Ther Health Med. 2003 Mar-Apr;9(2):38-45.

 

Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients.

Psychosom Med. 2003 Jul-Aug;65(4):571-81.

 

[1] 24. Scanga CB, Verde TH, Paolone AM, Andersen RE, Wadden TA.  Effects of weight loss and exercise training on natural killer cell activity in obese women.  Med Sci Sports Exercise 1998; 30(12):1666-71.

 

Shade ED, Ulrich CM, Wener MH, Wood B, Yasui Y, Lacroix K, Potter JD, McTiernan A.  Frequent intentional weight loss is associated with lower natural killer cell cytotoxicity in postmenopausal women: possible long-term immune effects.  J Am Diet Assoc. 2004 Jun;104(6):903-12.

 

25. Nieman DC, Henson DA, Gusewitch G, Warren BJ, Dotson RC, Butterworth DE, Nehlsen-Cannarella SL. Physical activity and immune function in elderly women.  Med Sci Sports Exerc 1993; 25: 823-831

 

Yan H, Kuroiwa A, Tanaka H, Shindo M, Kiyonaga A, Nagayama A.  Effect of moderate exercise on immune senescence in men.  Eur J Appl Physiol. 2001 Dec;86(2):105-11.

 

Nieman DC. Exercise immunology: practical applications.  International Journal of Sports Medicine.  18 (Suppl) 1:S91-100, 1997

 

Nieman DC, Nehlsen-Cannarella SL, Markoff PA, Balk-Lamberton AJ, Yang H, Chritton DB, Lee JW, Arabatzis K.  The effects of moderate exercise training on natural killer cells and acute upper respiratory tract infections.  Int J Sports Med 1990; 11: 467-473

 

26. Lakier Smith L. Overtraining, excessive exercise, and altered immunity: is this a T helper-1 versus T helper-2 lymphocyte response? Sports Med. 2003;33(5):347-64.

 

27.  Barone J,  Hebert JR,  Reddy MM. Dietary fat and natural killer cell activity.  Am J Clin Nutr 1989; 50: 861-867

 

Malter M,  Schriever G,  Eilber U.  Natural killer cells, vitamins, and other blood components of vegetarian and omnivorous men. Nutrition & Cancer.  1989; 12(3):271-8

 

Adams DO.  Molecular biology of macrophage activation: a pathway where by psychosocial factors can potentially affect health.  Psychosomatic Medicine.  1994; 56: 316-327.

 

Huang SC, Misfeldt ML, Fritsche KL. Dietary fat influences Ia antigen expression in immune cell populations in murine peritoneum and spleen.  J Nutr 1992; 122: 1219-1231.

 

Guimarães AR, Costa Rosa LF, Safi DA, Curi R. Metabolic and functional changes in macrophages of rats fed polyunsaturated or saturated fat, acid-rich diets during aging.  Biochem Int 1992; 27: 9-16

 

Gogos CA, Skoutelis A, Kalfarentzos F. The effects of lipids on the immune response of patients with cancer.  Journal of Nutrition, Health & Aging. 4(3):172-5, 2000

 

Kelley DS.  Modulation of human immune and inflammatory responses by dietary fatty acids.  Nutrition. 17(7-8):669-73, 2001.

 

28. Kelley DS.  Modulation of human immune and inflammatory responses by dietary fatty acids.  Nutrition. 17(7-8):669-73, 2001

 

Garritson BK, Nikaein A, Peters GN, Gorman MA, King CC, Liepa GU.   Effect of major dietary modifications on the immune system in patients with breast cancer.  Cancer Practice  1995; 3(4): 239-246

 

Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F.  Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized  control trial.  Cancer.  1998; 82(2):395-402.

 

Smyth GP, Stapleton PP, Barden CB, Mestre JR, Freeman TA, Duff MD, Maddali S, Yan Z, Daly JM. Renal cell carcinoma induces prostaglandin E2 and T-helper type 2 cytokine production in peripheral blood mononuclear cells. Ann Surg Oncol. 2003 May;10(4):455-62.

 

29. Cavallo MG, Fava D, Monetini L, Barone F, Pozzilli P. Cell-mediated immune response to beta casein in recent-onset insulin-dependent diabetes: implications for disease pathogenesis. Lancet. 348(9032):926-8, 1996

 

30. Watanabe A, Okada K, Shimizu Y, Wakabayashi H, Higuchi K, Niiya K, Kuwabara Y, Yasuyama T, Ito H, Tsukishior T, Kondoh Y, Emi N, Kohri H.  Nutritional therapy of chronic hepatitis by whey protein (non-heated).  J Med 2000; 31(5-6):283-302.

 

Bounous G.  Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer Res. 2000; 20(6C):4785-92.

 

See D, Mason S, Roshan R.  Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers. Immunol Invest. 2002; 31(2):137-53

 

31. Suomalainen H, Isolauri E, Kaila M, Virtanen E, Arvilommi H. Cow's milk provocation induces an immune response to unrelated dietary antigens. Gut. 33(9):1179-83, 1992

 

Ota F, Yamamoto S, Takeuchi S., Akiyama M, Kido Y, Kishi K, Hirota K, Fukui K. Effects of protein intake on immune parameters in mice surviving streptococcal infection. FEMS Microbiology Immunology. 4(2):111-22, 1992

 

32. Good MF, Powell LW, Halliday JW.  Iron status and cellular immune competence. Blood Reviews. 2(1):43-9, 1988

 

Walker EM Jr, Walker SM.  Effects of iron overload on the immune system. Annals of Clinical & Laboratory Science. 30(4):354-65, 2000

 

Boldt DH.  New perspectives on iron: an introduction.  American Journal of the Medical Sciences. 318(4):207-12, 1999

 

Blanc JF, Bioulac-Sage P, Balabaud C.  Iron overload and cancer.  Bulletin de l’ Academie Nationale de Medecine. 184(2):355-63, 2000

 

Milman N, Sengelov H., Dombernowsky P.  Iron status markers in patients with small cell carcinoma of the lung. Relation to survival.  British Journal of Cancer. 64(5):895-8, 1991

 

33. Boynton A, Neuhouser ML, Wener MH, Wood B, Sorensen B, Chen-Levy Z, Kirk EA, Yasui Y, Lacroix K, McTiernan A, Ulrich CM. Associations between healthy eating patterns and immune function or inflammation in overweight or obese postmenopausal women. Am J Clin Nutr. 2007 Nov;86(5):1445-55.

 

Garritson BK, Nikaein A, Peters GN, Gorman MA, King CC, Liepa GU.  Effect of major dietary modifications on immune system in patients with breast cancer.  Cancer Pract 1995; 3(4):239-46.

 

Hebert JR,  Barone J,  Reddy MM,  Backlund JY.  Natural killer cell activity in a longitudinal dietary fat intervention trial. Clinical Immunology & Immunopathology.  1990; 54(1):103-16

 

Hubbard NE, Somers SD, Eriskson KL.  Effect of dietary fish oil on development and selected functions of murine inflammatory macrophages.  J Leukoc Biol.  1991;  49: 592

 

Erickson KL,  Hubbard NE.  A possible mechanism by which dietary fat can alter tumorigenesis: lipid modulation of macrophages function. Advances in Experimental Medicine & Biology.  1994; 364:67-81.

 

Adams DO. Molecular biology of macrophage activation: a pathway whereby psychosocial factors can potentially affect health. Psychosomatic Medicine.  1994;56(4):316-27.

 

34. Ishikawa H, Saeki T, Otani T, Suzuki T,Shimozuma K, Nishino H, Fukuda S, Morimoto K. Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer.  J Nutr. 2006 Mar;136(3 Suppl):816S-820S

 

Lamm DL, Riggs DR. Enhanced immunocompetence by garlic: role in bladder cancer and other malignancies. J Nutr. 2001 Mar;131(3s):1067S-70S.

 

35. Vojdani A, Ghoneum M.  In vivo effect of ascorbic acid on enhancement of human natural killer cell activity.  Nutrition Research 1993; 13: 753-754

 

Vojdani A,  Namatalla G.  Enhancement of human natural killer cytotoxic activity by vitamin C inpure and augmented formulations.  Journal of Nutritional and Environmental Medicine 1997; 7(3): 187-195

 

Kiremidjian-Schumacher L,  Roy M, Wishe HI  et al.  Supplementation with selenium augments the functions of natural killer and lymphokine-activated killer cells. Biological Trace Element Research.  1996; 52(3):227-39

 

Petrie HT, Klassen LW,  Klassen PS  et al.  Selenium and the immune response: 2. Enhancement of murine cytotoxic T-lymphocyte and natural killer cell cytotoxicity in vivo. Journal of Leukocyte Biology.  1989; 45(3):215-20

 

Nair MP,  Schwartz SA.  Immunoregulation of natural and lymphokine-activated killer cells by selenium. Immunopharmacology.  1990; 19(3):177-83

 

Sprietsma JE.  Modern diets and diseases: NO-zinc balance. Under Th1, zinc and nitrogen monoxide (NO) collectively protect against viruses, AIDS, autoimmunity, diabetes, allergies, asthma, infectious diseases, atherosclerosis and cancer.  Medical Hypotheses. 53(1):6-16, 1999

 

Waatzl B, Bub A, Brandstetter BR, Rechenkemmer G.  Modulation of human T-lymphocyte functions by the consumption of carotenoid-rich vegetables.  Br J Nutr 1999; 82(5):383-9.

 

Stahelin HB.  Critical reappraisal of vitamins and trace minerals in nutritional support of cancer patients.  Support Care Cancer 1993; 1: 295-297

 

Itoh K, Kumagai K.  Augmentation of NK activity by several anti-inflammatory agents.  Proceedings of the International Symposium on Natural Killer Activity and Its Regulation.  (Fifth International Congress of Immunoloyg). 1983.  See also:  Brutkiewicz RR, Suzuk S.  Antitumor mechanisms of germanium sesquioxide  (GE-132)  in experimental murine ascites tumors.  Brit J Cancer 1985; 52: 757-63;  see also: Watson RR, Prabhala RH, Plezia PM, Alberts DS. Effect of beta-carotene on lymphocyte subpopulations in elderly humans: evidence for a dose-response realtionship.  Am J Clin Nutr.  1991; 53: 90-94

 

36. Gogos CA, Ginopoulos P, Zoumbos NC, Apostolidou E.,Kalfarentzos F. The effect of dietary omega-3 polyunsaturated fatty acids on T-lymphocyte subsets of patients with solid tumors. Cancer Detection & Prevention.  19(5):415-7, 1995

 

37. Tashiro T, Yamamori H, Morishima Y, Sugiura T, Hayashi N, Furukawa K, Nakajima N, Itoh I. N-3 polyunsaturated fatty acids in surgical nutrition.  Journal of Japan Surgical Society. 99(4):256-63, 1998

 

38. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC.  Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged > 55 y.  Am J Clin Nutr 2001; 73(3):539-48.

 

Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Xoumbos NC, Kalfarentzos F.  Dietary omega-3 polynsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy:  a randomized controlled trial.  Cancer 1998; 82(2):395-402.

 

39. Vojdani A, Ghoneum M.  In vivo effect of ascorbic acid on enhancement of human natural killer cell activity.  Nutrition Research 1993; 13: 753-754.

 

40. Del Rio M,  Ruedas G,  Medina S,  Victor VM,  De la Fuente M. Improvement by several antioxidants of macrophage function in vitro.  Life Sciences. 1998;63(10):871-81.

 

Abbey M, Nestel PJ, Baghurst PA. Antioxidant vitamins and low-density lipoprotein oxidation.   Am J Clin Nutr  1993; 58: 525-32

 

Heuser G,  Vojdani A.  Enhancement of natural killer cell activity and T and B cell function by buffered vitamin C in patients exposed to toxic chemicals: the role of protein kinase-C. Immunopharmacology & Immunotoxicology. 1997;19(3):291-312.

 

41. Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions.  Ann Nutr Metab. 2006;50(2):85-94.

 

42. Kiremidjian-Schumacher L, Roy M, Wishe HI  et al.  Supplementation with selenium augments the functions of natural killer and lymphokine-activated killer cells. Biological Trace Element Research.  1996; 52(3):227-39

 

Petrie HT,  Klassen LW,  Klassen PS  et al.  Selenium and the immune response: 2. Enhancement of murine cytotoxic T-lymphocyte and natural killer cell cytotoxicity in vivo. Journal of Leukocyte Biology.  1989; 45(3):215-20

 

Nair MP,  Schwartz SA.  Immunoregulation of natural and lymphokine-activated killer cells by selenium. Immunopharmacology.  1990; 19(3):177-83

 

43. McCulloch M, See C, Shu X-J, Broffman M, Kramer A, Wei-yu Fan W-Y, et al. Astragalus-Based Chinese Herbs and Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Meta-Analysis of Randomized Trials. J Clin Oncol 2006;24(3):419-430.

 

Block KI, Mead MN.  Immune system effects of Echinacea, ginseng and astragalus: a review.  Integr Cancer Ther. 2003; 2(3):247-67.

 

44. Rittenhouse JR, Lui PD, Lau BH.  Chinese medicinal herbs reverse macrophage suppression induced by urological tumors. J Urol. 1991 Aug;146(2):486-90.

 

45. Ahn WS, Kim DJ, Chae GT, Lee JM, Bae SM, Sin JI, Kim YW, Namkoong SE, Lee IP. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. Int J Gynecol Cancer. 2004 Jul-Aug;14(4):589-94.

 

Sorimachi K, Akimoto K, Ikehara Y, Inafuku K, Okubo A, a title="Click to search for citations by this author." href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_AbstractPlus&term=%22Yamazaki+S%22%5BAuthor%5D"> Yamazaki S. Secretion of TNF-alpha, IL-8 and nitric oxide by macrophages activated with Agaricus blazei Murill fractions in vitro. Cell Struct Funct. 2001 Apr;26(2):103-8.

 

46. Zheng R, Jie S, Hanchuan D, Moucheng W. Characterization and immunomodulating activities of polysaccharide from Lentinus edodes. Int Immunopharmacol. 2005 May;5(5):811-20.

 

47. Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients.  Immunol Invest. 2003 Aug;32(3):201-15.

 

You YH, Lin ZB. Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species.  Acta Pharmacol Sin. 2002 Sep;23(9):787-91.

 

48. Kidd PM.  The use of mushroom glucans and proteoglycans in cancer treatment.  Altern Med Rev 2000; 5(1):4-27.

 

Fisher M, Yang LX.  Anticancer effects and mechanisms of polysaccharide-K (PSK):  implications of cancer immunotherapy.  Anticancer Res 2002; 22(3):1737-54.

 

Ng TB. A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae).  Gen Pharmacol. 1998 Jan;30(1):1-4.

 

49. Yamaguchi N, Yoshida J, Ren LJ, Chen H, Miyazawa Y, Fujii Y, Huang YX, Takamura S, Suzuki S, Koshimura S et al.  Augmentation of various immune reactivities of tumor-bearing hosts with an extract of Cordyceps sinensis.  Biotherapy 1990; 2(3):199-205.

 

Gao Q, Wuu G, He D.  Effect of Cordyceps sinensis on the Th1/Th2 cytokines in patients with condylomata acuminate.  Zhong Yao Cai 2000; 23(7):402-4.

 

50. Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients.  Immunol Invest. 2003 Aug;32(3):201-15.

 

51. Lewkowicz P, Banasik M, Głowacka E, Lewkowicz N, Tchórzewski H. [Effect of high doses of shark liver oil supplementation on T cell polarization and peripheral blood polymorphonuclear cell function] Pol Merkur Lekarski. 2005 Jun;18(108):686-92.

 

Gurańska N, Lewkowicz P, Urbaniak B, Banasik M, Głowacka E, Lauk-Puchała B, Peterson R, Tchórzewski H. [The assessment of the effectiveness of the shark liver oil in recurrent aphthous stomatitis treatment: clinical and immunological studies]. Pol Merkur Lekarski. 2001 Sep;11(63):233-8.

 

52. Zhang Z, Song Y, Wang XL. Inositol hexaphosphate-induced enhancement of natural killer cell activity correlates with suppression of colon carcinogenesis in rats. World J Gastroenterol. 2005 Aug 28;11(32):5044-6.

 

Baten A, Ullah A, Tomazic VJ, Shamsuddin AM. Inositol-phosphate-induced enhancement of natural killer cell activity correlates with tumor suppression. Carcinogenesis. 1989 Sep;10(9):1595-8.

 

53. Srinivasan V, Maestroni GJ, Cardinali DP, Esquifino AI, Perumal SR, Miller SC. Melatonin, immune function and aging. Immun Ageing. 2005 Nov 29;2:17.

 

54. Groom SN, Johns T, Oldfield PR. The potency of immunomodulatory herbs may be primarily dependent upon macrophage activation. J Med Food. 2007 Mar;10(1):73-9.

 

Lersch C, Zeuner M, Bauer A, Siebenrock K, Hart R, Wagner F, Fink U, Dancygier H, Classen M. Stimulation of the immune response in outpatients with hepatocellular carcinomas by low doses of cyclophosphamide (LDCY), echinacea purpurea extracts (Echinacin) and thymostimulin. Arch Geschwulstforsch. 1990;60(5):379-83.

 

55. Shin HJ, Kim YS, Kwak YS, Song YB, Kim YS, Park JD. Enhancement of antitumor effects of paclitaxel (taxol) in combination with red ginseng acidic polysaccharide (RGAP). Planta Med. 2004 Nov;70(11):1033-8.

 

Xie FY, Zeng ZF, Huang HY. Clinical observation on nasopharyngeal carcinoma treated with combined therapy of radiotherapy and ginseng polysaccharide injection] Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001 May;21(5):332-4.

 

56. Ishikawa H, Saeki T, Otani T, Suzuki T, Shimozuma K, Nishino H, Fukuda S, Morimoto K. Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer. J Nutr. 2006 Mar;136(3 Suppl):816S-820S.

 

57. Wu D, Meydani SN. Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. J Leukoc Biol. 2008 Jul 2. [Epub ahead of print]

 

58. Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions.  Ann Nutr Metab. 2006;50(2):85-94.

 

59. Popovic PJ, Zeh HJ 3rd, Ochoa JB. Arginine and immunity. J Nutr. 2007 Jun;137(6 Suppl 2):1681S-1686S.

 

60. Kumar A.  Cimetidine: an immunomodulator. DICP. 1990 Mar;24(3):289-95.

 

Mavligit GM.  Immunologic effects of cimetidine: potential uses. Pharmacotherapy. 1987;7(6 Pt 2):120S-124S

[1]

Takahashi K, Tanaka S, Ichikawa A.  Effect of cimetidine on intratumoral cytokine expression in an experimental tumor. Biochem Biophys Res Commun. 2001; 281(5):1113-9.

 

Bai D, Yang G, Yuan H, Li Y, Wang K, Shao H.  Perioperative cimetidine application modulates natural killer cells in patients with colorectal cancer: a randomized clinical study. J Tongji Med Univ. 1999;19(4):300-3.

 

Adams WJ, Morris DL, Ross WB, Lubowski DZ, King DW, Peters L.  Cimetidine preserves non-specific immune function after colonic resection for cancer. Aust N Z J Surg. 1994 Dec;64(12):847-52.

 

Adams WJ, Morris DL.  Pilot study--cimetidine enhances lymphocyte infiltration of human colorectal carcinoma: results of a small randomized control trial. Cancer. 1997 Jul 1;80(1):15-21.

 

Tonnesen H, Knigge U, Bulow S, Damm P, Fischerman K, Hesselfeldt P, Hjortrup A, Pedersen IK, Pedersen VM, Siemssen OJ, et al.  Effect of cimetidine on survival after gastric cancer. Lancet. 1988 Oct 29;2(8618):990-2.

 

Matsumoto S, Imaeda Y, Umemoto S, Kobayashi K, Suzuki H, Okamoto T. Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br J Cancer. 2002; 86(2):161-7.

 

Nagano T, Matsuda H, Park YC, Kurita T.  Successful treatment of metastatic renal cell carcinoma with cimetidine--report of two cases. Nippon Hinyokika Gakkai Zasshi. 1996 Oct;87(10):1201-4

 

61. Wilson KS. Clinical activity of celecoxib in metastatic malignant melanoma. Cancer Invest. 2006 Dec;24(8):740-6.

 

Gogas H, Polyzos A, Stavrinidis I, Frangia K, Tsoutsos D, Panagiotou P, Markopoulos C, Papadopoulos O, Pectasides D, Mantzourani M, Middleton M, Vaiopoulos G, Fountzilas G. Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group. Ann Oncol. 2006 Dec;17(12):1835-41.

 

Rini BI, Weinberg V, Dunlap S, Elchinoff A, Yu N, Bok R, Simko J, Small EJ. Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma. Cancer. 2006 Feb 1;106(3):566-75.

 

Dovedi SJ, Kirby JA, Davies BR, Leung H, Kelly JD. Celecoxib has Potent Antitumour Effects as a Single Agent and in Combination with BCG Immunotherapy in a Model of Urothelial Cell Carcinoma. Eur Urol. 2008 Jan 15. [Epub ahead of print]

 

62. Dovio A, Caramello V, Masera RG, Sartori ML, Saba L, Tinivella M, Prolo P, Termine A, Avagnina P, Angeli A.  Natural killer cell activity and sensitivity to positive and negative modulation in uncomplicated obese subjects :  relationships to leptin and diet composition.  Int J Obes Relat Metab Disord 2004; 28(7):894-901.

 

63. Nieman DC. Exercise immunology: practical applications.  International Journal of Sports Medicine.  18 (Suppl) 1:S91-100, 1997

 

Nieman, DC et al.  The effects of moderate exercise training on natural killer cells and acute upper respiratory tract infections.  Int J Sports Med 1990; 11: 467-473

 

Nieman, DC. et al.  Physical activity and immune function in elderly women.  Med Sci Sports Exerc 1993; 25: 823-831

 

64. Wei H, Sun R, Xiao W, Feng J, Zhen C, Xu X, Tian Z. Traditional Chinese medicine Astragalus reverses predominance of Th2 cytokines and their up-stream transcript factors in lung cancer patients. Oncol Rep. 2003 Sep-Oct;10(5):1507-12.

 

Zheng R, Jie S, Hanchuan D, Moucheng W. Characterization and immunomodulating activities of polysaccharide from Lentinus edodes. Int Immunopharmacol. 2005 May;5(5):811-20.

 

Kodama N, Komuta K, Nanba H. Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients. J Med Food. 2003 Winter;6(4):371-7.

 

Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab. 2006;50(2):85-94.